Get the Stockscreener App
8.92
1.87%
-0.17
After Hours:
9.68
0.76
+8.52%
Carlsmed Inc stock is traded at $8.92, with a volume of 131.90K.
It is down -1.87% in the last 24 hours and down -8.32% over the past month.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
See More
Previous Close:
$9.09
Open:
$9.1
24h Volume:
131.90K
Relative Volume:
1.03
Market Cap:
$242.91M
Revenue:
$50.51M
Net Income/Loss:
$-29.63M
P/E Ratio:
-7.7843
EPS:
-1.1459
Net Cash Flow:
-
1W Performance:
-1.65%
1M Performance:
-8.32%
6M Performance:
-26.28%
1Y Performance:
+0.00%
1-Day Range:
$8.805
$9.295
1-Week Range:
$8.50
$9.60
52-Week Range:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
858-295-9290
Address
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
8.92 | 247.54M | 50.51M | -29.63M | 0 | -1.1459 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Initiated | BTIG Research | Buy |
| Aug-18-25 | Initiated | BofA Securities | Buy |
| Aug-18-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Initiated | Piper Sandler | Overweight |
| Aug-18-25 | Initiated | Truist | Buy |
Carlsmed Inc Stock (CARL) Latest News
Carlsmed Earnings Call Highlights Growth, Rising Costs - TipRanks
Carlsmed Q1 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Carlsmed (CARL) Q1 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: Carlsmed Q1 2026 shows strong revenue growth - Investing.com
Carlsmed (NASDAQ:CARL) Shares Surge on Q1 Earnings Beat and Raised Full-Year Guidance - ChartMill
Carlsmed® Reports First Quarter 2026 Financial Results - The Manila Times
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. (NASDAQ:CARL) Sees Large Drop in Short Interest - MarketBeat
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed (CARL) Stock Outlook | Q4 2025: Profit Exceeds ViewsInvestment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Carlsmed (CARL) Stock: Why Market Expansion (Slight Loss) 2026-04-16Trending Volume Leaders - UBND thành phố Hải Phòng
Carlsmed, Inc. (NASDAQ:CARL) Short Interest Up 23.4% in March - MarketBeat
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛
CARL Maintains Buy Rating -- Price Target Lowered to $18.00 by T - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Cut to $18.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $18 - 富途牛牛
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Cuts Target Price to $23 - 富途牛牛
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance
The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World
Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat
CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI
CARL Technical Analysis & Stock Price Forecast - Intellectia AI
CARL News & Events - Intellectia AI
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - The Manila Times
CARL Stock Analysis: Carlsmed Inc medical tech gains 6.41 percent trading at 9.63 - Cổng thông tin điện tử tỉnh Lào Cai
Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World
Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Carlsmed reports Q4, FY 2025 revenue above estimate - MSN
Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com
Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal
Carlsmed joins Russell 2000 Index following Q3 IPO - MSN
Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World
Comparing Carlsmed (CARL) & The Competition - Defense World
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed unveils custom cervical plating tech - MSN
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World
Carlsmed Inc Stock (CARL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):